Mishima, Eikan https://orcid.org/0000-0002-3706-2745
Nakamura, Toshitaka https://orcid.org/0000-0002-4248-2058
Zheng, Jiashuo https://orcid.org/0000-0002-5387-1358
Zhang, Weijia https://orcid.org/0009-0006-5746-7164
MourĂ£o, AndrĂ© Santos Dias
Sennhenn, Peter
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Article History
Received: 13 September 2022
Accepted: 30 May 2023
First Online: 5 July 2023
Competing interests
: M.C. and P.S. hold patents for some of the compounds described herein, and are co-founders and shareholders of ROSCUE Therapeutics.